Logo

American Heart Association

  16
  0


Final ID: MP2521

Reducing Medicare 30-day heart failure readmissions and saving dollars with an aggressive “4 Weeks 4 Meds” heart failure clinic

Abstract Body (Do not enter title and authors here): Background
Medicare heart failure readmissions are costly. The Hospital Readmissions Reduction Program (HRRP) penalizes hospitals for high rates of Medicare 30-day heart failure (HF) readmissions. Decreasing HF readmissions is a fundamental goal of compassionate, cost-efficient heart failure care. Utilization of the four pillars of guideline-directed medical therapy (GDMT) can help reduce heart failure readmissions.

Question
Does establishing an aggressive, GDMT-centric HF clinic decrease Medicare 30-day HF readmissions?

Goals/Aims
Demonstrate the value of a physician-led HF clinic designed to reduce readmissions within a 285-bed hospital community.
Demonstrate the value of 4 Weeks 4 Meds – a clinical algorithm predicated on aggressive initiation and uptitration of the four pillars of GDMT.

Methods
From 2016 to 2024, Medicare 30-day HF readmissions data were tracked from Centerpoint Medical Center, a 285-bed hospital in Kansas City, Missouri. Annual HRRP penalties were tracked over this period. Beginning in 2022, a physician-led HF clinic consisting of one physician (0.5 FTE), two nurse practitioners (0.8 FTE total), one RN (0.8 FTE), and a dedicated HF-phone line was created. HF clinic utilized an early, aggressive guideline directed medication strategy in patients with reduced ejection fraction. Twice weekly multidisciplinary HF meetings were established with a dedicated inpatient HF RN Navigator (1.0 FTE) who maintained good standing with AHA-GWTG and GWTG-IMPLEMENT HF registries. Also included in these meetings: Inpatient pharmacy, cardiac rehab, case management, and hospital/clinic administration. Medicare 30-day readmissions data was then compared before and after the establishment of our community HF clinic.

Results/Data
Between 2016 and 2024, Centerpoint medical center averaged 110 Medicare HF admissions per year. From 2016 to 2021, 18.4% of Medicare primary HF admissions were readmitted within 30 days. After establishing a HF clinic, from 2022 to 2024 Medicare 30-day HF readmissions decreased to 13.5% (p 0.01). Annual Medicare HRRP penalties decreased from the maximum 3.00% of Medicare revenue in 2019 to 0.17% in 2023, an annual penalty savings in excess of one million USD.

Conclusion
In this example, a physician-led HF clinic reduced 30-day Medicare HF readmissions and helped lower costly HRRP penalties. Not shown in this economic data - the improved quality of life and patient years added with an aggressive community-based heart failure team.
  • Dickson, Steve  ( HCA Kansas City , Leawood , Kansas , United States )
  • Anderson, Jesse  ( HCA Kansas City , Leawood , Kansas , United States )
  • Freidhof, Sandi  ( HCA Kansas City , Leawood , Kansas , United States )
  • Schumaker, Amy  ( HCA Kansas City , Leawood , Kansas , United States )
  • Wong, Jennifer  ( HCA Kansas City , Leawood , Kansas , United States )
  • Glazier, Jennifer  ( HCA Kansas City , Leawood , Kansas , United States )
  • Turner, Christina  ( HCA Kansas City , Leawood , Kansas , United States )
  • Author Disclosures:
    Steve Dickson: DO have relevant financial relationships ; Speaker:Boehringer Ingelheim:Active (exists now) ; Speaker:Novo Nordisk:Past (completed) | Jesse Anderson: DO NOT have relevant financial relationships | Sandi Freidhof: No Answer | Amy Schumaker: DO NOT have relevant financial relationships | Jennifer Wong: DO NOT have relevant financial relationships | Jennifer Glazier: DO NOT have relevant financial relationships | Christina Turner: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Bridging the Gaps: Innovative Strategies in Heart Failure Care Delivery

Monday, 11/10/2025 , 01:45PM - 02:55PM

Moderated Digital Poster Session

More abstracts on this topic:
Artificial Intelligence Enabled Prediction of Future Structural Heart Disease and Cardiovascular Risk from Single-lead Electrocardiograms

Dhingra Lovedeep, Oikonomou Evangelos, Khera Rohan, Aminorroaya Arya, Pedroso Aline, Khunte Akshay, Sangha Veer, Brant Luisa, Barreto Sandhi, Ribeiro Antonio Luiz, Krumholz Harlan

5-oxoproline/ OPLAH Axis Alleviates Doxorubicin-induced Cardiomyopathy By Inhibiting Ferroptosis

Jiang Meng, Guo Xinning

You have to be authorized to contact abstract author. Please, Login
Not Available